During the past decade, River City Clinical Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "River City Clinical Research" #1 sponsor was "LivaNova" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Quark Pharmaceuticals" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "AcelRx Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "River City Clinical Research" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Clinical Accelerator" with 1 trials as a collaborator, "Everest Clinical Research" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "River City Clinical Research" are "Acute Kidney Injury" (3 trials), "Diabetic Foot Ulcers" (3 trials), "Aortic Stenosis" (2 trials), "Cardiovascular Disease" (2 trials) and "Aortic Aneurysm, Abdominal" (1 trials). Many other conditions were trialed in "River City Clinical Research" in a lesser frequency.

Most popular intervention types in "River City Clinical Research" are "Drug" (12 trials), "Device" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "ABP 654" (1 trials), "ANG-3777" (1 trials) and "CELSTAT" (1 trials). Other intervention names were less common.

The vast majority of trials in "River City Clinical Research" are 21 trials for "All" genders.

Currently, there are NaN active trials in "River City Clinical Research". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in River City Clinical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in River City Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".